S&P 5007,623.68▼0.5% Nasdaq25,955.34▼0.2% Dow52,215.16▼1.2% Russell 2K2,775.90▼0.3% 10-Yr4.99%+4bp VIX19.45+0.42 WTI$103.44▲4.0% Gold$4,010.00▼1.2% EUR/USD1.120▼0.3% BTC$80,550▼0.9% Nikkei62,908▼2.6%
At close · Sat, Oct 24, 2026
Daily Market Updates.

Earnings

Home›Earnings›Results›Cologuard Is Working,So Why Isn’t Abbott Stock?

Cologuard Is Working,So Why Isn’t Abbott Stock?

Reported · Written up by our desk · Results

Abbott's stock fell 4% despite solid Q3 results, as it trimmed full-year sales guidance and announced plans to spin off its Nutrition business into a separate public company by 2027.

← Newer storyMoody’s establishes casualty risk intelligence group with six foundin…

More like this

EarningsSpotify Soars After Earnings as the Company Touts AI Benefits and Moderating Costs
EarningsLockheed Martin’s Record $292 Billion Backlog Comes With a Delivery Test
EarningsPalantir's Next Big Test Isn't a Partnership,It's the Numbers
EarningsKinder Morgan's $4.7 Billion Pipeline Bet Could Be Bigger Than Its Earnings Beat
EarningsCapital One Earnings: After a Double Beat the Rally Is On

Sources

MarketBeat RatingsCologuard Is Working,So Why Isn’t Abbott Stock?

Get the close, explained.

One email every trading day: what moved, why it moved, and what's on deck tomorrow. Read in 3 minutes.

Free. Unsubscribe anytime.